pI: 8.5726 |
Length (AA): 316 |
MW (Da): 35746 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
152 | 243 | 3ndq (A) | 136 | 228 | 50.00 | 0 | 1 | 1.04854 | -2 |
156 | 315 | 3gtm (S) | 148 | 308 | 34.00 | 0 | 1 | 0.766829 | 1.26 |
268 | 316 | 1tfi (A) | 2 | 50 | 76.00 | 0 | 1 | 1.04946 | -0.47 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127402)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G38560 | transcript elongation factor IIS |
Babesia bovis | BBOV_I002910 | transcription factor S-II (TFIIS)and transcription factor S-II (TFIIS) central domain containing protein |
Brugia malayi | Bm1_17615 | transcription elongation factor S-II (TFIIS) |
Candida albicans | CaO19.12012 | transcriptional elongation factor |
Candida albicans | CaO19.4537 | transcriptional elongation factor |
Caenorhabditis elegans | CELE_T24H10.1 | Protein T24H10.1 |
Cryptosporidium hominis | Chro.80505 | transcription elongation factor TFIIS.h |
Cryptosporidium parvum | cgd8_4400 | transcription elongation factor TFIIS |
Dictyostelium discoideum | DDB_G0278241 | RNA polymerase II elongation factor |
Drosophila melanogaster | Dmel_CG3710 | RNA polymerase II elongation factor |
Echinococcus granulosus | EgrG_000670900 | transcription elongation factor A SII 1 |
Entamoeba histolytica | EHI_055430 | transcription factor S-II (TFIIS) domain protein |
Echinococcus multilocularis | EmuJ_000670900 | transcription elongation factor A (SII), 1 |
Homo sapiens | ENSG00000187735 | transcription elongation factor A (SII), 1 |
Homo sapiens | ENSG00000204219 | transcription elongation factor A (SII), 3 |
Leishmania braziliensis | LbrM.24.0200 | transcription elongation factor, putative |
Leishmania donovani | LdBPK_240200.1 | transcription elongation factor, putative |
Leishmania infantum | LinJ.24.0200 | transcription elongation factor, putative |
Leishmania major | LmjF.24.0210 | transcription elongation factor, putative |
Leishmania mexicana | LmxM.24.0210 | transcription elongation factor, putative |
Loa Loa (eye worm) | LOAG_14863 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10358 | hypothetical protein |
Mus musculus | ENSMUSG00000001604 | transcription elongation factor A (SII), 3 |
Mus musculus | ENSMUSG00000033813 | transcription elongation factor A (SII) 1 |
Neospora caninum | NCLIV_000590 | transcription elongation factor TFIIS, putative |
Oryza sativa | 4334559 | Os03g0815900 |
Oryza sativa | 4342769 | Os07g0229700 |
Plasmodium berghei | PBANKA_1421100 | transcription elongation factor s-II, putative |
Plasmodium falciparum | PF3D7_0714500 | transcription elongation factor s-II, putative |
Plasmodium knowlesi | PKNH_1423400 | transcription elongation factor s-II, putative |
Plasmodium vivax | PVX_122950 | transcription elongation factor, putative |
Plasmodium yoelii | PY01302 | transcription elongation factor TFIIS.h, putative |
Saccharomyces cerevisiae | YGL043W | Dst1p |
Schistosoma japonicum | Sjp_0053470 | ko:K03145 transcription elongation factor S-II, putative |
Schistosoma mansoni | Smp_007660 | transcription elongation factor s-II |
Schmidtea mediterranea | mk4.001393.02 | Putative transcription elongation factor S-II |
Trypanosoma brucei gambiense | Tbg972.11.5600 | transcription elongation factor, putative |
Trypanosoma brucei | Tb927.11.4960 | transcription elongation factor s-II, putative |
Trypanosoma congolense | TcIL3000.11.4990 | transcription elongation factor, putative |
Trypanosoma cruzi | TcCLB.507857.10 | transcription elongation factor, putative |
Trypanosoma cruzi | TcCLB.507669.100 | transcription elongation factor, putative |
Toxoplasma gondii | TGME49_293670 | transcription elongation factor A TFIIS |
Theileria parva | TP01_0553 | transcription elongation factor SII, putative |
Trichomonas vaginalis | TVAG_032660 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.2600 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.2600 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.2600 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.2600 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1421100 | Plasmodium berghei | Essential | plasmo |
TGME49_293670 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.